An educational social clip that says it doesn't sell peptides or give dosing. Details beyond the disclaimer are thin.
Recap by typeshit. Video by @brianpeeler on TikTok.
Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
A short clip of Rosie O'Donnell discussing the tirzepatide drug Mounjaro. Few details are given beyond the title.
Sam Stone mixed GLP-1 Daily Support powder into a smoothie daily and came away with stomach aches and doubts about what it does.
Dr Desmond Wai shares the Novo Nordisk news and notes the FDA cleared semaglutide for fatty liver disease in the US more than a year earlier.
Designed enzymes that cut protein chains rely on zinc activating water placed beside the peptide, and AI models can miss it.
The law firm explains what Lilly's retatrutide suits mean for pharmacies, telehealth companies and online sellers, as the drug maker goes after unapproved versions.
Loading…